NLRC5 and neoplasm: Cancer cell lines representative of different cancer types and primary cancer specimens transfected or treated with NLRC5 coding nucleic acids will not only upregulate MHC-I expression but also APM genes that will facilitate processing and presentation of tumor antigenic peptides to boost the power of proteogenomic cancer neoantigen discovery.